Harry Jacobson, MD

Dr. Jacobson is the Chairman of MedCare Investment Funds. Previously, Dr. Jacobson was Vice Chancellor for Health Affairs at Vanderbilt University (CEO of Vanderbilt University Medical Center (“VUMC”)). During Dr. Jacobson’s tenure, VUMC revenues grew from approximately $750 million to $2.5 billion; its Federally funded (NIH) research program moved from twenty-fourth to one of the top ten in the country; it opened over $1.0 billion of newly constructed facilities; it was recognized as a “most-wired” hospital as well as a U. S. News and World Report honor-roll hospital; and, most recently, it was recognized as a Fortune top-100 place to work. Importantly, in his role at VUMC he participated in the oversight of technology transfer operations that resulted in the creation of over 30 companies.

During the course of his career, Dr. Jacobson has been a successful investor and entrepreneur, having founded or co-founded eight companies, including (i) Contact Software (the developer of Act!, the world’s leading contact management software), which was acquired by Symantec (SYMC: NASDAQ); (ii) Renal Care Group (RCG: NYSE), a leading dialysis service company, acquired by Fresenius Medical Care (FMS: NYSE); (iii) Ambulatory Services of America, a diversified outpatient ancillary services provider of dialysis and radiation oncology services; (iv) Cardiovascular Care Group, an integrated provider of cardiovascular services (and its predecessor Cardiovascular Services of America); (v) Quality Healthcare International, a manager/operator of international healthcare facilities in countries seeking 21st century health services for their citizens; (vi) digiChart, a healthcare information technology company focused on women’s health; (vii) Informatics Corporation of America, an early-stage healthcare informatics company creating electronic medical records for regional health information organizations, large healthcare systems, hospitals and multisite practices; and (viii) CeloNova Biosciences, a medical device company with 2 CE-approved and 1 FDA-approved products.

Previously Dr. Jacobson served on the Board of Directors of Merck & Company, Inc. (MRK: NYSE), and currently serves on the Board of Directors of Ingram Industries and SpecialtyCare Inc., as well as on the Boards of several other healthcare companies. In 2002 he was named the Ernst and Young Southeast Entrepreneur of the Year and was recently ranked No. 35 on Modern Physician’s ranking of the 50 Most Powerful Physician Executives in Healthcare. Dr. Jacobson is also a past chair of the Nashville Health Care Council Board of Directors.